The University of Chicago Header Logo

Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma.

Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma. Cancer Immunol Immunother. 2009 Aug; 58(8):1351-3.

View in: PubMed